Baxter International Stock: Is Wall Street Bullish or Bearish? Baxter International has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects. Barchart · Feb 4, 2025
Earnings Preview: What To Expect From Baxter International's Report As Baxter International prepares to report its fourth-quarter earnings next month, analysts expect a double-digit profit dip. Barchart · Jan 21, 2025
How Is Baxter International's Stock Performance Compared to Other Medical Devices Stocks? Baxter International has lagged behind its peers in the medical devices industry over the past three months, and analysts are cautious about the stock's prospects. Barchart · Dec 26, 2024
Baxter International Stock: Analyst Estimates & Ratings Due to Baxter International’s underperformance relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects. Barchart · Nov 4, 2024
Baxter International's Quarterly Earnings Preview: What You Need to Know Baxter International is all set to announce its third-quarter results next month, with analysts predicting a double-digit growth in the company's earnings. Barchart · Oct 25, 2024
Baxter Stock: Is BAX Underperforming the Healthcare Sector? Baxter has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects. Barchart · Sep 27, 2024
Is Becton, Dickinson, and Company Stock Underperforming the Nasdaq? Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects. Barchart · Sep 10, 2024
3 High-Growth MedTech Stocks to Buy The medtech industry’s long-term growth is fueled by growing demand for medical devices, adoption of cutting-edge technologies, and improved efficiency. Thus, it could be ideal to buy fundamentally solid medtech stocks Baxter International (BAX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC) poised for substantial growth. Keep reading. StockNews.com · Aug 26, 2024
Do Wall Street Analysts Like Baxter International Stock? As Baxter International has underperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's prospects. Barchart · Aug 7, 2024
Baxter International's Q2 2024 Earnings: What to Expect Baxter International is poised to release its second-quarter results this month, and analysts are projecting a double-digit earnings growth. Barchart · Jul 12, 2024
3 Growth Stocks With P/E Ratios Below Industry Average Growth stocks trading at lower P/E ratio than the industry average can be a suitable investment choice. Top picks now could be Cardinal Health (CAH), Baxter International (BAX), and DocuSign (DOCU). Keep reading. StockNews.com · Jul 8, 2024
Is Becton, Dickinson and Company Stock Underperforming the S&P 500? Becton, Dickinson and Company has lagged the S&P 500 recently, but analysts are optimistic about the stock’s prospects. Barchart · Jun 20, 2024
Baxter International Stock Outlook: Is Wall Street Bullish or Bearish? Despite Baxter International’s relatively underwhelming performance over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects. Barchart · May 22, 2024
Analyst Ratings for Baxter Intl Analysts have provided the following ratings for Baxter Intl (NYSE:BAX) within the last quarter: Benzinga · Apr 29, 2022
Benzinga · Apr 28, 2022 Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook Baxter International Inc (NYSE:BAX) has posted Q1 revenue of $3.71 billion, beating the consensus of $3.68 billion, up 26% on a reported basis, 29% on a constant currency basis, and 3% on an operational basis. Adjusted EPS of $0.93 increased 22%, ahead of the consensus of $0.80. Baxter's newly acquired Hillrom businesses…
Benzinga · Apr 28, 2022 Recap: Baxter Intl Q1 Earnings Baxter Intl (NYSE:BAX) reported its Q1 earnings results on Thursday, April 28, 2022 at 07:15 AM. Here's what investors need to know about the announcement.
Benzinga · Apr 21, 2022 Death Cross Looms Over Baxter Intl Investors If history is any guide, there may be trouble ahead for shares of Baxter Intl (NYSE:BAX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Benzinga · Mar 14, 2022 FDA Issues To Class I Recall To Baxter's Spectrum Infusion Pump In December 2021, Baxter International Inc (NYSE: BAX) issued an urgent safety communication about an issue with some of its Spectrum infusion pumps.
Benzinga · Feb 18, 2022 Analyst Ratings For Baxter Intl Over the past 3 months, 6 analysts have published their opinion on Baxter Intl (NYSE:BAX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
StockNews.com · Feb 18, 2022 Stabilize Your Portfolio with These 5 High-Quality Stocks The stock indices are down, heading for a second straight losing week on investor concerns about geopolitical tensions and the Fed’s actions. And the market is expected to remain volatile in the near term. Hence, we think high-quality stocks Merck & Co. (MRK), Archer-Daniels-Midland (ADM), Baxter (BAX), McKesson (MCK), and…
Benzinga · Feb 17, 2022 Baxter Clocks Better-Than-Expected Q4 Earnings, But FY22 Guidance Trail Street View Baxter International Inc (NYSE: BAX) has posted Q4 revenue
Benzinga · Feb 17, 2022 Recap: Baxter Intl Q4 Earnings Baxter Intl (NYSE:BAX) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:15 AM. Here's what investors need to know about the announcement.
StockNews.com · Jan 31, 2022 Baxter International vs. Becton Dickinson: Which Medical Equipment & Supply Stock is a Better Buy? The demand for medical equipment & supplies is rising exponentially with the emergence of severe illnesses such as the ongoing Coronavirus pandemic and the growing elderly population. So, Baxter International (BAX) and Becton Dickinson and Company (BDX) should benefit. But which of these two stocks is a better buy now?…